Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
60 hedge funds and large institutions have $14.4M invested in Chembio diagnostics, Inc. in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 32 reducing their positions, and 25 closing their positions.
17% less funds holding
Funds holding: 72 → 60 (-12)
26% less call options, than puts
Call options by funds: $409K | Put options by funds: $556K
41% less capital invested
Capital invested by funds: $24.5M → $14.4M (-$10.1M)
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
81% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$814K |
| 2 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$380K |
| 3 |
E
Ergoteles
New York
|
+$313K |
| 4 |
Goldman Sachs
New York
|
+$240K |
| 5 |
Squarepoint
New York
|
+$228K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.71M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$769K |
| 3 |
State Street
Boston,
Massachusetts
|
-$675K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$581K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$544K |
CEMI Hedge Fund Activity: Q2 2021 in Review
60 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q2 2021, worth a combined $14.4M — down 41% from $24.5M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of CEMI and 13 opened new positions — a net loss of 12 holders — while 32 trimmed existing stakes and 6 added.
The largest buyer was Millennium Management, adding an estimated $814K. The largest seller was BlackRock, cutting an estimated $3.71M.
- 60 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q2 2021, down from 72 in Q1 2021.
- Funds reported $14.4M of Chembio diagnostics, Inc. stock for Q2 2021, down 41% quarter-over-quarter.
- 13 funds opened new Chembio diagnostics, Inc. positions in Q2 2021 and 25 closed out, a net change of -12 holders.
- The largest Chembio diagnostics, Inc. buyer in Q2 2021 was Millennium Management, an estimated $814K added.
- The largest Chembio diagnostics, Inc. seller in Q2 2021 was BlackRock, an estimated $3.71M sold.
Based on aggregated 13F filings for Q2 2021.